COMPARATIVE THE EFFETIVENESS OF THE AGELOC TR90 DIETARY SUPPLEMENT ON PRIMARY OVERWEIGHT AND OBESE PATIENTS

Minh Hoàn Vũ1, Thị Thanh Tú Nguyễn2,
1 Hanoi General Hospital of Traditional
2 HMU

Main Article Content

Abstract

Objective: To compare the effectiveness of the ageLOC TR90 dietary supplements on primary overweight and obese patients. Subjects: 20 patients diagnosed with primary overweight and 40 patients diagnosed with obesity in the community from January 2022 to December 2022. Methods: Clinical intervention study, comparing the results before and after treatment and between two groups. Results: After 90 days of using the product: The weight average index of the obese group decreased by 3.33 ± 1.80 (kg), which was higher than that of the overweight group (decreased by 1.95 ± 1.01 (kg) (p < 0.05); BMI average index of the obese group decreased by 1.27 ± 0.67, which was higher than that of the overweight group (decreased by 0.80 ± 0.39) (p < 0.05). The waist circumference average of the obese group decreased lower than that of the overweight group (p > 0.05); The hip circumference average, the thigh circumference, the upper arm circumference average and the calf circumference average of the obese group decreased higher than that of the overweight group (p > 0.05). Conclusions: The weight average index and the BMI average index of obese patients group decreased significantly compared with the overweight patients group (p < 0.05); Others average index (the hip circumference, thigh circumference, the upper arm circumference and the calf circumference) of obese patients group decreased not significantly compared with the overweight patients group (p > 0.05).

Article Details

References

1. Kết quả điều tra quốc gia yếu tố nguy cơ bệnh không lây nhiễm ở Việt Nam. Accessed June 12, 2022. https://tihe.org.vn/tin-tuc/chi-tiet/176-Ket-qua-dieu-tra-quoc-gia-yeu-to-nguy-co-benh-khong-lay-nhiem-o-Viet-Nam.
2. Đỗ Trung Quân (2015), Bệnh nội tiết chuyển hóa thường, Nhà xuất bản y học, tr.313-323.
3. Von Lengerke Thomas, Krauth Christian (2011), "Economic costs of adult obesity: a review of recent European studies with a focus on subgroup-specific costs", Maturitas, 69(3), pp. 220-229.
4. Obesity and overweight. Accessed June 15, 2022. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
5. Song HJ, Hwang J, Pi S, et al. The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013. PloS One. 2018;13(5):e0197057. doi:10.1371/journal.pone.0197057.
6. Pharmanex. A Phase IV, Open-Label, Parallel Group, Single-Center Study on the Effects of a Nutritional Supplement Combination on Body Weight Management Over a 90-Day Period. clinicaltrials.gov; 2014. Accessed November 9, 2022. https://clinicaltrials.gov/ct2/show/NCT01725958.
7. Karimi-Nazari E, Nadjarzadeh A, Masoumi R, et al. Effect of saffron (Crocus sativus L.) on lipid profile, glycemic indices and antioxidant status among overweight/obese prediabetic individuals: A double-blinded, randomized controlled trial. Clin Nutr ESPEN. 2019;34:130-136. doi:10.1016/ j.clnesp.2019.07.012.
8. Makino-Wakagi Y, Yoshimura Y, Uzawa Y, Zaima N, Moriyama T, Kawamura Y. Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes. Biochem Biophys Res Commun. 2012;417(2):880-885. doi:10.1016/j.bbrc.2011.12.067.